期刊： DIABETES CARE, 2022; 45 (5)
OBJECTIVE The comparative neuroprotective effects of different antidiabetes drugs have not been characterized in randomized controlled trials. Here, w......
期刊： DIABETES CARE, 2022; 45 (11)
OBJECTIVE Patients with type 2 diabetes are at higher risk for fracture risk because of attenuated bone turnover and impaired bone microarchitecture. ......
期刊： DIABETES CARE, 2022; 45 (12)
OBJECTIVE The Risk Assessment and Management Programme-Diabetes Mellitus (RAMP-DM) is a protocol-driven, risk-stratified, and individualized managemen......
期刊： DIABETES CARE, 2022; 45 (4)
OBJECTIVEIn recent years, some studies have indicated that a novel marker described as the stress hyperglycemia ratio (SHR) can reflect true acute hyp......
期刊： DIABETES CARE, 2022; 45 (4)
OBJECTIVEWe aimed to investigate prospective associations of pulse wave arterial stiffness index (ASI) and pulse pressure (PP) with type 2 diabetes (T......
期刊： DIABETES CARE, 2022; 45 (2)
OBJECTIVE Despite that periodical monitoring of cobalamin (vitamin B12) in metformin-treated patients with diabetes is recommended, cobalamin-associat......
期刊： DIABETES CARE, 2022; 45 (8)
OBJECTIVE To investigate whether the association between insulin resistance and cardiovascular disease (CVD) differs by glucose tolerance status. RESE......
期刊： DIABETES CARE, 2022; 45 (10)
OBJECTIVE Atrial fibrillation (AF) frequently occurs in patients with type 2 diabetes (T2D); however, the longitudinal associations of new-onset AF wi......
期刊： DIABETES CARE, 2022; 45 (6)
OBJECTIVE Although carotenoids have been suggested to exhibit antioxidant properties, some experimental studies reported that beta-carotene may show p......
